US Patent 8129343 Acylated GLP-1 compounds
Patent 8129343 was granted and assigned to Novo Nordisk on March, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 20, 2006
0
Date of Patent
March 6, 2012
0
Patent Application Number
11908834
0
Patent Inventor Names
Jesper Lau
0
Paw Bloch
0
Thomas Kruse Hansen
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8129343 Acylated GLP-1 compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.